ArticleAnnals of surgical oncology2022

Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Carlos E Guerra-Londono et al.PubMed ↗Publisher ↗

No numbers read from the abstract.